GSK tops forecasts as consumer health spin-off nears
GlaxoSmithKline is pressing on with the spin-off of its consumer health business, now called Haleon, even though many companies have delayed or abandoned listing plans amid market jitters over the Ukraine crisis GlaxoSmithKline (GSK) beat first-quarter sales and earnings forecasts on Wednesday, April 27, helped by demand for its COVID-19 therapy and shingles vaccine, as … Read more